CDSCO mandates application process for license of r-DNA products to be only through ONDLS portal: Gireesh Babu, New Delhi ...
If NIH prioritizes human-based science in its ongoing overhaul of biosafety policies, the oversight system that has evolved for review of a wide-swath of biological research could atrophy and expose ...
Recombinant DNA Infectious organisms and viruses (like parasites, bacteria, fungi, prions, and viroids) Biologically active agents (like toxins, allergens, and venoms) Human blood and blood products ...
The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...
The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...
CDSCO has mandated online submission of applications for licences to manufacture and sell r-DNA-origin drugs through the ...
The Central Drugs Standard Control Organization (CDSCO) has announced that all applications related to Post Approval Changes ...
Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results